Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Apr;37(4):545–552. doi: 10.1038/bjc.1978.83

Lymphocyte Defect in Plasmacytoma-bearing Mice

I Brus, J Brent, V P Hollander
PMCID: PMC2009570  PMID: 646925

Abstract

Multiple myeloma is often associated with humoral immunodepression in both man and mouse. When mice bearing the humorally immunodepressive plasmacytomas TEPC-183 and SPQC-11 were injected with SRBC, the rise of serum haemolysins was significantly less than that of non-tumour-bearing mice. Mice with the plasmacytomas MPC-11 and MOPC-315 have an antibody response similar to normal mice when injected with SRBC. Following immunization, normal mice and those bearing MPC-11 showed a 2- to 3-fold increase in total spleen lymphocytes. Mice bearing TEPC-183 or SPQC-11, the plasmacytomas causing an impaired antibody response, has significant increase in spleen lymphocytes under the same conditions. Mice bearing MOPC-315 had a very high initial count of spleen lymphocytes, which did not further increase upon immune stimulation.

Incubation of lymphocytes from plasmacytoma-bearing mice with PHA did not produce an increase in TdR incorporation and in some cases even caused a decrease in TdR incorporation.

Lymphocytes from mice bearing TEPC-183, SPQC-11, and MOPC-315 incorporated less TdR in response to LPS than did normal mice. On the other hand, mice bearing MPC-11 incorporated about as much TdR as did normal mice following LPS stimulation. Thus, the defect in the ability to respond to LPS in vitro correlated with the lack of an increase of spleen lymphocytes in mice bearing these tumours following antigenic stimulation in vivo.

No immunodepressive properties of serum from mice with plasmacytoma could be detected.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson B., Blomgren H. Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. Cell Immunol. 1971 Oct;2(5):411–424. doi: 10.1016/0008-8749(71)90052-9. [DOI] [PubMed] [Google Scholar]
  2. CONE L., UHR J. W. IMMUNOLOGICAL DEFICIENCY DISORDERS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA. J Clin Invest. 1964 Dec;43:2241–2248. doi: 10.1172/JCI105098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen Y., Bhoopalam N., Yakulis V., Heller P. Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor. Ann Intern Med. 1975 Nov;83(5):625–631. doi: 10.7326/0003-4819-83-5-625. [DOI] [PubMed] [Google Scholar]
  4. Dammacco F., Clausen J. Antibody deficiency in paraproteinemia. Acta Med Scand. 1966 Jun;179(6):755–768. doi: 10.1111/j.0954-6820.1966.tb05500.x. [DOI] [PubMed] [Google Scholar]
  5. FAHEY J. L., HUMPHREY J. H. Effect of transplantable plasma-cell tumors on antibody response in mice. Immunology. 1962 Jan;5:110–115. [PMC free article] [PubMed] [Google Scholar]
  6. Gershon R. K., Gery I., Waksman B. H. Suppressive effects of in vivo immunization on PHA responses in vitro. J Immunol. 1974 Jan;112(1):215–221. [PubMed] [Google Scholar]
  7. Gery I., Krüger J., Spiesel S. Z. Stimulation of B-lymphocytes by endotoxin. Reactions of thymus-deprived mice and karyotypic analysis of dividing cells in mice bearing T 6 T 6 thymus grafts. J Immunol. 1972 Apr;108(4):1088–1091. [PubMed] [Google Scholar]
  8. Heller P., Bhoopalam N., Cabana V., Costea N., Yakulis V. The role of RNA in the immunological deficiency of plasmacytoma. Ann N Y Acad Sci. 1973 May 31;207:468–480. doi: 10.1111/j.1749-6632.1973.tb47509.x. [DOI] [PubMed] [Google Scholar]
  9. Hirano S., Imamura Y., Takaku F., Nakao K. Immune response in mice with plasma-cell tumor (X5563) assayed by agar plaque technique. Blood. 1968 Feb;31(2):252–257. [PubMed] [Google Scholar]
  10. Jones S. V., McFarlane H. T and B cells in myelomatosis. Br J Haematol. 1975 Dec;31(4):545–552. doi: 10.1111/j.1365-2141.1975.tb00889.x. [DOI] [PubMed] [Google Scholar]
  11. LAWSON H. A., STUART C. A., PAULL A. M., PHILIPS A. M., PHILIPS R. W. Observations on the antibody content of the blood in patients with multiple myeloma. N Engl J Med. 1955 Jan 6;252(1):13–18. doi: 10.1056/NEJM195501062520103. [DOI] [PubMed] [Google Scholar]
  12. MARKS J. Antibody formation in myelomatosis. J Clin Pathol. 1953 Feb;6(1):62–63. doi: 10.1136/jcp.6.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Peavy D. L., Adler W. H., Smith R. T. The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol. 1970 Dec;105(6):1453–1458. [PubMed] [Google Scholar]
  14. Tanapatchaiyapong P., Zolla S. Humoral immunosuppressive substance in mice bearing plasmacytomas. Science. 1974 Nov 22;186(4165):748–750. doi: 10.1126/science.186.4165.748. [DOI] [PubMed] [Google Scholar]
  15. ZINNEMAN H. H., HALL W. H. Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Ann Intern Med. 1954 Dec;41(6):1152–1163. doi: 10.7326/0003-4819-41-6-1152. [DOI] [PubMed] [Google Scholar]
  16. Zolla-Pazner S., Sullivan B., Richardson D. Cellular specificity of plasmacytoma-induced immunosuppression. J Immunol. 1976 Aug;117(2):563–568. [PubMed] [Google Scholar]
  17. Zolla S., Naor D., Tanapatchaiyapong P. Cellular basis of immunodepression in mice with plasmacytomas. J Immunol. 1974 Jun;112(6):2068–2076. [PubMed] [Google Scholar]
  18. Zolla S. The effect of plasmacytomas on the immune response of mice. J Immunol. 1972 Apr;108(4):1039–1048. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES